Clinical trial · Observational
Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Observational Epidemiological Study of Cancer-associated Thrombosis: Registry of Thrombosis & NEoplasia of SEOM (TESEO Study)
NCT03855592CI-TRIAL-00089820TESEOrecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Epidemiological, observational, non-interventional, multicentric study on patients diagnosed with cancer who develop a venous or arterial thromboembolic episode, symptomatic or incidental, within a month prior to cancer diagnosis or at anytime after such diagnosis
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Thromboembolism | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (8)
- measure
- Location of origin of the thromboembolytic event
- timeFrame
- Baseline
- description
- Distribution in the number of patients according to the anatomical location affected by the thromboembolytic event.
- measure
- Vessel of origin of the thromboembolytic event
- timeFrame
- Baseline
- description
- Distribution in the number of patients according to the type of vessel affected by the thromboembolytic event.
- measure
- Thromboembolytic event diagnosis type
- timeFrame
- Baseline
- description
- Proportion of patients with incidental versus symptomatic thormboembolic events
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years of age with a histologically confirmed diagnosis of malignant tumor. * Venous or arterial thromboembolism episode, symptomatic or incidental, in the month prior or any time after the cancer diagnosis and in the three previous months to enrollment, confirmed with an imaging technique: Doppler echocardiography, computed tomography (CT) angiography, etc. * Signing of informed consent. Exclusion Criteria: * Clinical diagnosis of thromboembolic event without radiological confirmation. * Presenting a single episode of superficial thrombophlebitis without association with another thromboembolic event. * Each patient will be recorded just once, and therefore a second thromboembolic event will be considered a rethrombosis and will be recorded as such. Patients with a rethrombosis and a previous thromboembolic event before the start of the study in each center will not be able to be included.
References
Publications (0)
Data not yet available
No reference posted for this study.